|
一、項目名稱中藥提取及保健品項目二、項目單位簡介山東圣旺藥業股份有限公司主要從事獸藥飼料、甜菊糖、中藥提取、保健食品等的生產，資產總額1.2億元，注冊資本1104萬元。三、項目內容及建設規模項目擬新上舒慮安等中草藥提取200噸、鹽酸二甲雙胍及治療胃病新藥500噸、甜菊糖系列保健品、銀杏靈芝膠囊等產品，總占地面積108畝，建筑面積3萬平方米。四、項目建設條件該項目位于曲阜工業園內，基礎設施已實現七通一平，達到開工條件。五、項目總投資及資金來源總投資1400萬美元。六、市場及經濟效益分析預測中藥提
取項目為國內先進水平，胃病新藥為國家級新藥。年新增銷售收入1800萬美元、利稅120萬美元。七、合作方式合資。八、聯系方式聯系地址：曲阜市春秋路1號郵政編碼：273100聯系人：陳志偉聯系電話：0086-537-4498326傳真：0086-537-4498325電子郵箱：weijessie@sohu.comTCMextractions and healthcare products of Shandong ShengwangPharmaceutical Co., Ltd. (totalinvestment 14 million USD)1. ProjectnameTCM extractions and healthcare products2. Brief introduction tothe project unitWith 120million yuan of total asset and 11.04million yuan of registeredcapital, Shandong ShengwangPharmaceutical Co., Ltd. mainly dealswith animal drug, fodder,stevia rebausianum, herb extracts, andhealth foods.3. Projectcontents and construction scaleThe projectincludes 200 tons of herbextracts, 500 tons of hydrochloricmelbine and new tummy bug drugs,stevia rebaudianum series healthfoods, gingko and tinder agariccapsules, etc. The project covers108 mu of land with 30,000 squaremeters of floor area.4.Construction conditionsLocated in theIndustrial Park of Qufu City,the project can now be started withits infrastructure constructionalready completed.5. Total projectinvestment and fundresourcesTotal investment is USD 14 million .6.Market andfinancial benefit analysis and forecastHerb extractionproject isof advanced level in China and the tummy bug drugs arestate-levelnew medicine. After completion of the project, it isexpected torealize an annual sales income of USD 18 million yuanwith a taxand profit of USD 1.2 million yuan.7. CooperationformJointventure8. Means of contactAdd：Chunqiu Rd 1#,QufuCityPostcode：273100Contact：ChenZhiweiTel：+86-537-4498326Fax：+86-537-4498325Email：weijessie@sohu.com（信息來源：濟寧市地方商務之窗）
（信息來源：山東地方商務之窗子站）
文章類型：
|
